FABP5 and neoplasm: The proposed nanocarrier integrates cyclic arginine‐glycine‐aspartic acid (cRGD) and red blood cell membrane (RBCM), encapsulating superparamagnetic iron oxide (SPIO) to specifically target fatty acid‐binding protein 5 (FABP5) in tumor cells.